Investor insights
Sectors invested in
Funding rounds participated in
$1.5M sweet spot round size
Most of their 19 investments are in rounds between $12M and $53M
Investor type
Basic info
Industry
Sectors
Date founded
2018
Investments made
Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $53M on April 27, 2023
Investors: GV, Canaan, Lumira Ventures, Sofinnova Ventures, Russia technology fund, BioImpact Capital and Adjuvant Capital
Codagenix Inc. raised $25M on February 15, 2023
Investors: Adjuvant Capital
InDevR raised $9M on January 17, 2023
Investors: Adjuvant Capital
Undisclosed raised $23M on December 15, 2022
Investors: Pureos Bioventures, REPAIR Impact Fund, Sanofi Ventures, Industrifonden, Wellington Partners, Sunstone Life Science Ventures, Trill Impact and Adjuvant Capital
UNIVERCELLS raised $43M on October 19, 2022
Investors: SRIW, 3d investors, -, AdBio partners, SFPI-FPIM, TheClubDeal SA and Adjuvant Capital
Memo Therapeutics AG raised $25M on February 16, 2022
Investors: Zürcher Kantonalbank, Fresenius Medical Care, Vesalius Biocapital and Adjuvant Capital
VitriVax raised undisclosed on July 7, 2021
Investors: Adjuvant Capital
PULMOCIDE LIMITED raised $92M on May 27, 2021
Investors: 旭化成ファーマ（株）, IP Group plc, Longwood Fund, S.R. One Ltd, F-Prime Capital Partners, JEITO, SV Life Sciences and Adjuvant Capital
Excision BioTherapeutics raised $60M on February 17, 2021
Investors: Cota Capital, ARTIS Ventures, Indusage Partners, Norwest Venture Partners, Anzu Partners, WRVI Capital, GreatPoint Ventures, Olive Tree Capital and Adjuvant Capital
Frontier Nutrition, Inc. raised $6M on February 3, 2021
Investors: DSM Venturing, GreatPoint Ventures and Adjuvant Capital